SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001563665-23-000004
Filing Date
2023-01-12
Accepted
2023-01-12 09:23:03
Documents
4
Period of Report
2023-01-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230111x8k.htm 8-K 40562
2 EX-10.1 tmb-20230111xex10d1.htm EX-10.1 161002
3 EX-99.1 tmb-20230111xex99d1.htm EX-99.1 12011
4 GRAPHIC tmb-20230111xex99d1001.jpg GRAPHIC 9827
  Complete submission text file 0001563665-23-000004.txt   228703
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 23525073
SIC: 3841 Surgical & Medical Instruments & Apparatus